The satiety effect of GLP1-agonists reduces your food intake, appetite and hunger
One app
Teixeira CF, da Cruz IBM, Ribeiro EE, Pillar DM, Turra BO, Praia RS, Barbisan F, Alves AO, Sato DK, Assmann CE, Palma TV, Barcelos RP, Barbosa IM, Azzolin VF (2021) Safety indicators of a novel multi supplement based on guarana, selenium, and L-carnitine: e4vidence from human and red earthworm immune cells
Oncotarget 6 , 41264143 (2015)
Preclinical and clinical studies demonstrate BBRs multimodal anti-obesity mechanisms: (i) adenosine monophosphate-activated protein kinase (AMPK) activation enhancing lipolysis and -oxidation, (ii) peroxisome proliferator-activated receptor (PPAR-) suppression inhibiting adipogenesis, (iii) gut microbiota modulation improving metabolic endotoxemia, and (iv) uncoupling protein 1 (UCP1) upregulation promoting adipose browning